DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

01099 SINOPHARM

Closed Add to Porfolio
Index Constituent : Hang Seng Index, HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, HS China (HK) 100, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders Sinopharm Industrial Investment Co., Ltd. (50.36%)
China National Pharmaceutical Group Corporation (6.64%)		 Sector Health Care & Biotechnology
Web Site http://www.sinopharm.com/ Tel (86 10) 8228-7727
Email N/A Fax (86-10) 6203-3332
Related Equities N/A
Principal Activities The Group is mainly engaged in: (1) the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics, (2) the distribution of medical devices, (3) the operation of chain pharmacy stores, and (4) the distribution of laboratory supplies, manufacture and distribution of chemical reagents, and production and sale of pharmaceutical products.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
JPMorgan Chase & Co. 250,672,887(L) 3,354,632(S) 230,041,040(P)  21.01(L) 0.28(S) 19.28(P)  19/10/2018
Oppenheimer Developing Markets Fund 142,587,200(L) 0(S) 0(P)  11.95(L) 0.00(S) 0.00(P)  07/12/2018
BlackRock, Inc. 84,040,322(L)  7.05(L)  11/02/2019
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
于清明 100,000(L)  0.01(L)  28/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top